You might be in lock down but your money can still work for you.

Find out how to invest on the right side of the Corona pandemic and learn why the future of Medical Commercial Real Estate in the US is so resilient.


 


 

Join us on this Webinar where Martin Freeman, Machiel Lucas and Hennie Bezuidenhoudt share new information with you on Medical Real Estate trends in the US and why it is still a low risk asset class.

We will also share with you our new real estate investment opportunity - make sure not to miss out as we are very excited about this special opportunity in Dallas, Texas!

Not available for the webinar?
Not a problem, register below and even if you miss out, we will automatically send you a link to the recording so you can watch in your own time.

"We have an enormous responsibility when it comes to managing our investors money and this is a key part of our strategy. As I’ve mentioned many times before, our strategy has always been centered around the preservation of clients capital."
- OrbVest CEO, Martin Freeman

**NOTE: Certain restrictions apply to some countries and Jurisdictions. OrbVest SA (PTY) LTD operates under licence in South Africa in terms of the Financial Advisory and Intermediary Services Act, No 37 of 2002. Licence No. 41690, the relevant issuer files in the USA under Reg 506(c).

 

The solution is here.

Hundreds of investors from across South Africa are investing in medical and senior living real estate in the USA, sourced by a highly skilled team, who invest alongside you.

 
 

Our simple solution you can count on

We make investing in global real estate simple. Whether you’re a small or large investor, you can invest from as little as $5,000 and earn quarterly dividends in US Dollars.

 

With OrbVest, clients use an online platform to invest directly into low risk commercial assets, primarily in the Healthcare sector. The investments generate regular dividends (±8% per annum) that are distributed on a quarterly basis creating annuity income and long-term wealth over the period of investment. (Targeted IRR of 12% to 17%).